NUPR1 and cancer: In summary, the observed synergistic cytotoxic effects of doxorubicin–ATZ-502 combination treatment in various cancer cell lines support the hypothesis that nuclear translocation of NUPR1 requires the NUPR1 binding to karyopherin β1.